Stocks and securities in focus
Security | Change (%) | 1w | 1m ▼ | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Personalis Inc | -5.460% | -7.660% | 68.081% | 225.084% | 132.404% | -74.423% | - |
Inspire Medical Systems Inc. | -0.030% | 7.372% | 32.119% | -20.670% | -3.946% | -6.276% | - |
Applovin Corp. | -4.670% | -9.236% | 20.817% | 93.553% | 109.218% | 15.545% | - |
Denali Therapeutics Inc. | -1.450% | 2.986% | 13.065% | -1.172% | 14.660% | -50.251% | - |
Adagene Inc. | -3.820% | 1.613% | 9.565% | 113.559% | 69.128% | -81.333% | - |
Floor & Decor Holdings Inc. | -3.570% | -5.392% | 8.427% | 6.395% | -6.311% | -7.212% | - |
Terns Pharmaceuticals Inc. | 0.760% | -3.650% | 0.000% | 38.365% | 8.374% | -37.143% | - |
Immunocore Holdings Plc | -2.440% | -7.362% | -13.714% | -43.019% | -51.680% | 5.594% | - |
Bicycle Therapeutics Ltd. | -1.620% | -7.000% | -16.964% | -7.000% | 12.727% | -44.970% | - |
Aligos Therapeutics Inc. | -0.910% | - | - | - | - | - | - |
Chemomab Therapeutics Ltd. | -7.870% | - | - | - | - | - | - |
Atara Biotherapeutics Inc. | - | - | - | - | - | - | - |
Perspective Therapeutics Inc. | - | - | - | - | - | - | - |
Exagen Inc. | 2.340% | - | - | - | - | - | - |
Viridian Therapeutics Inc. | -7.690% | - | - | - | - | - | - |
Immatics N.v. | -2.420% | - | - | - | - | - | - |
Addex Therapeutics Sa | -2.070% | - | - | - | - | - | - |
Igm Biosciences Inc. | -3.410% | - | - | - | - | - | - |
Mirum Pharmaceuticals Inc. | -1.060% | - | - | - | - | - | - |
Chemometec As | 6.580% | - | - | - | - | - | - |
Pharvaris N.v. | 9.930% | - | - | - | - | - | - |
Sagimet Biosciences Inc. | -3.850% | - | - | - | - | - | - |
Alector Inc. | -1.940% | - | - | - | - | - | - |
Assembly Biosciences Inc. | 1.340% | - | - | - | - | - | - |
Delcath Systems Inc. | 2.660% | - | - | - | - | - | - |
Q32 Bio Inc. | 1.630% | - | - | - | - | - | - |
Spero Therapeutics Inc. | -0.170% | - | - | - | - | - | - |
Newamsterdam Pharma Company Nv | 2.050% | - | - | - | - | - | - |
Marinus Pharmaceuticals Inc. | -1.590% | - | - | - | - | - | - |